|
Nectar Lifesciences Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
381.02 Cr.
|
P/BV
|
0.40
|
Book Value (Rs.)
|
42.63
|
|
52 Week High/Low (Rs.)
|
44/13
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
21/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | -161.53 | 18.27 | -42.42 | 34.08 | -59.45 |
| | | | | | |
| Net CashFlow From Operating Activities | 169.44 | 224.69 | 133.65 | 95.01 | 21.38 |
| Net Cash Used In Investing Activities | -41.93 | -17.03 | 51.70 | 16.64 | -28.62 |
| Net Cash Used From Financing Activities | -128.09 | -205.44 | -185.58 | -119.38 | 11.49 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.58 | 2.23 | -0.23 | -7.73 | 4.25 |
| Cash And Cash Equivalents Begin of Year | 19.81 | 17.58 | 17.81 | 25.54 | 21.29 |
| Cash And Cash Equivalents End Of Year | 19.22 | 19.81 | 17.58 | 17.81 | 25.54 |